Unravelling pituitary tumours in medically treated patients with acromegaly: the impact of systematic MRI reassessment

• Published in: Acta radiologica (1987) p. 2841851241246107
• Main Authors: Atai, Shahriar, Knudtzon Andersen, Martin, Wiedmann, Markus, Dahlberg, Daniel, Øystese, Kristin Astrid B, Bollerslev, Jens, Ringstad, Geir, Heck, Ansgar
• Format: Journal Article
• Language: English
• Published: England 01.07.2024
• Subjects: pituitary; acromegaly; adenoma; Magnetic resonance imaging; remnant tumor
• ISSN: 1600-0455
• DOI: 10.1177/02841851241246107

In acromegaly, the primary tumor is usually found during magnetic resonance imaging (MRI) of the pituitary gland. A remnant tumor after surgery is, however, harder to depict. When a tumor is missed, the remaining option is usually lifelong pharmacological treatment. To identify tumors by reassessment of all available MRI scans in pharmacologically treated patients, operated or not, and to compare our results with the routine MRI reports. Adult patients diagnosed with acromegaly and managed at a tertiary care center between 2005 and 2021 and currently on pharmacological treatment were included. MRI scans were evaluated in a standardized manner and classified independently by a radiologist and an endocrinologist into "certain," "suspected," or "no tumor." In case of disagreement, consensus was achieved with a senior neuroradiologist. The results were compared using the clinical radiologists' routine MRI reports. We identified certain and suspected tumors in 29/74 and 36/74 patients, respectively. No tumor was identified in nine patients. In five of these, no MRI contrast agent was given. Discrepancy between our results and the routine MRI reports was found in 31/74 patients (  = 0.01). In 22 patients, the routine reports described no tumor while we identified certain tumors in 2/22 patients and suspected tumors in 13/22 patients. In most patients with pharmacologically treated acromegaly, we identified a certain or suspected pituitary tumor. These findings were more frequent compared to the routine MRI reports. Based on our results, patients will be considered for a change in long-term treatment modality.